Investors Snag NTLA 11.7% Cheaper Than Its Secondary Stock Offering
October 05, 2021 at 13:52 PM EDT
Looking back to 98 days ago, Intellia Therapeutics Inc (NTLA) priced a 4,137,931 share secondary stock offering at $145.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
